Accenture plc (ACN) Q3 2025 Earnings Call Transcript
https://seekingalpha.com/article/4796168-accenture-plc-acn-q3-2025-earnings-call-transcript?source=feed_sector_transcripts
Jun 20, 2025 -
0
Dermata Therapeutics Says Phase 3 STAR-1 Study Of Xyngari To Treat Acne Met Primary Goals; Stock Up
https://www.rttnews.com/story.aspx?Id=3524842
Mar 27, 2025 - Dermata Therapeutics, Inc. (DRMA) Thursday reported positive topline results from the pivotal Phase 3 STAR-1 study of the company's lead product candidate Xyngari for the treatment of acne. The study met its primary goals. The company's shares were more than 50 percent up in pre-market.
0
This Magnificent Stock Has Made Many Millionaires, and Could Make More
https://www.fool.com/investing/2024/11/27/this-magnificent-stock-has-made-many-millionaires/?source=iedfolrf0000001
Nov 27, 2024 -
0